胆囊切除术对患有腹腔外科手术后低血糖症的患者的影响
相关实验视频
Updated: Jun 24, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
6.6K
Daniel Sardão1, Hugo Santos-Sousa2,3, Bárbara Peleteiro4,5,6,7
1Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal. danielalexsardao@gmail.com.
Obesity surgery
|June 6, 2024
概括
患有腹后低血糖症 (PBH) 的患者,先前接受了胆囊切除术,需要更高的阿卡尔剂量. 这突显了胆酸变化对葡萄糖代谢和PBH胆酸-GLP-1-胰岛素轴的影响.
科学领域:
- 内分泌学和新陈代谢学
- 腹部外科手术的结果
- 胃肠病学 胃肠病学
背景情况:
- 代谢手术是主要的肥胖治疗方法,但腹腔后低血糖症 (PBH) 是一个常见的并发症.
- PBH涉及胰岛素和GLP-1的升高,胆酸 (BA) 影响GLP-1的释放.
- 胆囊切除术可能会影响PBH,因为改变了BA代谢和荷尔蒙反应.
研究的目的:
- 调查胆囊切除术对PBH药理治疗的影响.
- 评估胆囊切除术对PBH诊断时间表的影响.
- 评估PBH患者的代谢参数,有或没有胆囊切除术史.
主要方法:
- 在131名PBH患者的逆向队列研究中,他们接受了腹腔外科手术后的治疗.
- 患者根据先前的胆囊切除术史进行了分层.
- 混合饮食耐受性测试 (MMTT) 用于评估代谢反应.
主要成果:
- 在131名PBH患者中,有29人有胆囊切除病史;诊断时间表相似.
- 以前进行胆囊切除术的患者需要更高的阿卡尔糖剂量 (p=0.046).
- 在胆囊切除组中,MMTT显示了更高的胰岛素和c-水平,以及更大的血糖变异性.
结论:
- 经过胆囊切除术的PBH患者需要更高的阿卡尔博斯剂量来治疗症状.
- 这些发现加强了高胰岛素在PBH病因学中的作用.
- 这项研究强调了胆酸-GLP-1-胰岛素轴在PBH中的重要性.
相关概念视频
Hypoglycemia and Glucagon
256
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
256
Acute Pancreatitis II: Clinical Manifestations and Management
118
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
118
Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
Oral Hypoglycemic Agents: Biguanides and Glitazones
189
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
189
Insulin: Dosing Regimen and Adverse Effects
166
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
166
Metabolic States of the Body: The Postabsorptive State
298
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
298

